Cargando…
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290389/ https://www.ncbi.nlm.nih.gov/pubmed/35834416 http://dx.doi.org/10.15585/mmwr.mm7128a3 |
| _version_ | 1784748888762089472 |
|---|---|
| author | Hause, Anne M. Baggs, James Marquez, Paige Abara, Winston E. Baumblatt, Jane Gwira Thompson, Deborah Su, John R. Myers, Tanya R. Gee, Julianne Shimabukuro, Tom T. Shay, David K. |
| author_facet | Hause, Anne M. Baggs, James Marquez, Paige Abara, Winston E. Baumblatt, Jane Gwira Thompson, Deborah Su, John R. Myers, Tanya R. Gee, Julianne Shimabukuro, Tom T. Shay, David K. |
| author_sort | Hause, Anne M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9290389 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92903892022-07-29 Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022 Hause, Anne M. Baggs, James Marquez, Paige Abara, Winston E. Baumblatt, Jane Gwira Thompson, Deborah Su, John R. Myers, Tanya R. Gee, Julianne Shimabukuro, Tom T. Shay, David K. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-07-15 /pmc/articles/PMC9290389/ /pubmed/35834416 http://dx.doi.org/10.15585/mmwr.mm7128a3 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report Hause, Anne M. Baggs, James Marquez, Paige Abara, Winston E. Baumblatt, Jane Gwira Thompson, Deborah Su, John R. Myers, Tanya R. Gee, Julianne Shimabukuro, Tom T. Shay, David K. Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022 |
| title | Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022 |
| title_full | Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022 |
| title_fullStr | Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022 |
| title_full_unstemmed | Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022 |
| title_short | Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022 |
| title_sort | safety monitoring of covid-19 mrna vaccine first booster doses among persons aged ≥12 years with presumed immunocompromise status — united states, january 12, 2022–march 28, 2022 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290389/ https://www.ncbi.nlm.nih.gov/pubmed/35834416 http://dx.doi.org/10.15585/mmwr.mm7128a3 |
| work_keys_str_mv | AT hauseannem safetymonitoringofcovid19mrnavaccinefirstboosterdosesamongpersonsaged12yearswithpresumedimmunocompromisestatusunitedstatesjanuary122022march282022 AT baggsjames safetymonitoringofcovid19mrnavaccinefirstboosterdosesamongpersonsaged12yearswithpresumedimmunocompromisestatusunitedstatesjanuary122022march282022 AT marquezpaige safetymonitoringofcovid19mrnavaccinefirstboosterdosesamongpersonsaged12yearswithpresumedimmunocompromisestatusunitedstatesjanuary122022march282022 AT abarawinstone safetymonitoringofcovid19mrnavaccinefirstboosterdosesamongpersonsaged12yearswithpresumedimmunocompromisestatusunitedstatesjanuary122022march282022 AT baumblattjanegwira safetymonitoringofcovid19mrnavaccinefirstboosterdosesamongpersonsaged12yearswithpresumedimmunocompromisestatusunitedstatesjanuary122022march282022 AT thompsondeborah safetymonitoringofcovid19mrnavaccinefirstboosterdosesamongpersonsaged12yearswithpresumedimmunocompromisestatusunitedstatesjanuary122022march282022 AT sujohnr safetymonitoringofcovid19mrnavaccinefirstboosterdosesamongpersonsaged12yearswithpresumedimmunocompromisestatusunitedstatesjanuary122022march282022 AT myerstanyar safetymonitoringofcovid19mrnavaccinefirstboosterdosesamongpersonsaged12yearswithpresumedimmunocompromisestatusunitedstatesjanuary122022march282022 AT geejulianne safetymonitoringofcovid19mrnavaccinefirstboosterdosesamongpersonsaged12yearswithpresumedimmunocompromisestatusunitedstatesjanuary122022march282022 AT shimabukurotomt safetymonitoringofcovid19mrnavaccinefirstboosterdosesamongpersonsaged12yearswithpresumedimmunocompromisestatusunitedstatesjanuary122022march282022 AT shaydavidk safetymonitoringofcovid19mrnavaccinefirstboosterdosesamongpersonsaged12yearswithpresumedimmunocompromisestatusunitedstatesjanuary122022march282022 |